NABNEC: A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/16/HAWKE/26.
SSA Reference Number: SSA/16/MonH/202.
Monash Health HREC Ref: 16284X
Effective start/end date12/12/1811/12/23